# Definium Therapeutics Highlights DT120 ODT (Lysergide Tartrate) Clinical Advancements and Commercial Strategy at Investor and Analyst Day

- URL: https://theranews.net/blog/2026-04-23-definium-therapeutics-highlights-dt120-odt-lysergide-tartrate-clinical-advanceme-d6bb32/
- Published: 2026-04-23
- Type: Archive summary (AI-assisted summary of third-party reporting)
- Original outlet: rutlandherald
- Original report: https://www.rutlandherald.com/news/business/definium-therapeutics-highlights-dt120-odt-lysergide-tartrate-clinical-advancements-and-commercial-strategy-at-investor-and/article_4f963fb3-0c70-51cd-acc7-9ea7d95d890a.html
- Topics: mental-health
- Publisher: TheraNews, operated by AdvancedCare USA Inc.
- Notice: Educational content, not medical, legal, billing or financial advice. Cite the original outlet, not this summary.

---
![Definium Therapeutics Highlights DT120 ODT (Lysergide Tartrate) Clinical Advancements and Commercial Strategy at Investor and Analyst Day](/uploads/news-images/definium-therapeutics-highlights-dt120-odt-lyserg-20260423110055.jpg)

---
*Originally reported by rutlandherald. [Read more](https://www.rutlandherald.com/news/business/definium-therapeutics-highlights-dt120-odt-lysergide-tartrate-clinical-advancements-and-commercial-strategy-at-investor-and/article_4f963fb3-0c70-51cd-acc7-9ea7d95d890a.html)*

---

*Source: [https://www.rutlandherald.com/news/business/definium-therapeutics-highlights-dt120-odt-lysergide-tartrate-clinical-advancements-and-commercial-strategy-at-investor-and/article_4f963fb3-0c70-51cd-acc7-9ea7d95d890a.html](https://www.rutlandherald.com/news/business/definium-therapeutics-highlights-dt120-odt-lysergide-tartrate-clinical-advancements-and-commercial-strategy-at-investor-and/article_4f963fb3-0c70-51cd-acc7-9ea7d95d890a.html)*